Trial intelligence / Profile preview

Kék Lukács ointment versus silver sulfadiazine for deep partial-thickness burns

2011-005037-39Phase 2Terminated

Sponsor
Lukács és Társa
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of Kék Lukács Ointment in burn injury and partial-thickness burn (2 arms), sponsored by Lukács és Társa. Primary endpoint: Percent reduction in wound surface area. Started Feb 2012; status: terminated.

02

Drugs

Kék Lukács Ointment
03

Conditions

burn injurypartial-thickness burn

Beyond the preview

Go deeper on 2011-005037-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005037-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call